Mithila Drugs Profile
Key Indicators
- Authorised Capital ₹ 1.20 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.20 Cr
as on 24-10-2024
- Company Age 29 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.57 Cr
as on 24-10-2024
- Satisfied Charges ₹ 24.35 Cr
as on 24-10-2024
- Revenue -15.66%
(FY 2023)
- Profit -406.65%
(FY 2023)
- Ebitda -143.39%
(FY 2023)
- Net Worth -17.59%
(FY 2023)
- Total Assets -17.89%
(FY 2023)
About Mithila Drugs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.20 Cr and a paid-up capital of Rs 1.20 Cr.
The company currently has active open charges totaling ₹10.57 Cr. The company has closed loans amounting to ₹24.35 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Jha, Arvind Jha, and Pramod Jha serve as directors at the Company.
- CIN/LLPIN
U24232RJ1995PTC009496
- Company No.
009496
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Feb 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Udaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Mithila Drugs Private Limited offer?
Mithila Drugs Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Antidiabetic Medicine, TB, Tumor & Cancer Drugs, Anti Cancer Injection, Common Disease Medicines, Injectable Products, Sexual Wellness Products, Contraceptives, Anti Cancer Medicines, Fertility Enhancer.
Who are the key members and board of directors at Mithila Drugs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Jha  | Director | 01-Dec-1996 | Current |
| Arvind Jha | Director | 09-Sep-2008 | Current |
| Pramod Jha | Director | 13-Feb-1995 | Current |
Financial Performance and Corporate Structure Insights of Mithila Drugs.
Mithila Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.66% decrease. The company also saw a substantial fall in profitability, with a 406.65% decrease in profit. The company's net worth observed a substantial decline by a decrease of 17.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mithila Drugs?
In 2023, Mithila Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 06 Jul 2020 | ₹4.70 M | Open |
State Bank Of India Creation Date: 06 Jul 2020 | ₹2.70 M | Open |
Others Creation Date: 29 Dec 2016 | ₹9.83 Cr | Open |
How Many Employees Work at Mithila Drugs?
Unlock and access historical data on people associated with Mithila Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mithila Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mithila Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
